Experienced in Myoclonic Epilepsy Associated With Ragged Red Fibers

Zaeem A. Siddiqi

Edmonton, AB, CA 
Experienced in Myoclonic Epilepsy Associated With Ragged Red Fibers
Edmonton, AB, CA 
OverviewLocationsClinical Research

Overview

Zaeem Siddiqi practices in Edmonton, Canada. Mr. Siddiqi is rated as an Experienced expert by MediFind in the treatment of Myoclonic Epilepsy Associated With Ragged Red Fibers. His top areas of expertise are Myasthenia Gravis, Familial Neurocardiogenic Syncope, Myotonic Dystrophy Type 2, and Myotonic Dystrophy.

His clinical research consists of co-authoring 50 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Myoclonic Epilepsy Associated With Ragged Red Fibers.

Gender
Male

Locations

Edmonton, AB, Canada
Other Locations
AB, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Extension of RVT-1401 in Myasthenia Gravis Patients
A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Extension of RVT-1401 in Myasthenia Gravis Patients
Enrollment Status: Completed
Publish Date: December 20, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Pilot Trial To Assess The Feasibility And Efficacy Of Subcutaneous Immunoglobulin In Patients With Myasthenia Gravis Exacerbation
A Pilot Trial To Assess The Feasibility And Efficacy Of Subcutaneous Immunoglobulin In Patients With Myasthenia Gravis Exacerbation
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Drug
Study Drug: Human normal immunoglobulin G
Study Phase: Phase 3
Prospective Multicenter Observational Cohort Study of Comparative Effectiveness of Disease-modifying Treatments for Myasthenia Gravis
Prospective Multicenter Observational Cohort Study of Comparative Effectiveness of Disease-modifying Treatments for Myasthenia Gravis
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
View 2 Less Clinical Trials

50 Total Publications

Feasibility of Subcutaneous Immunoglobulin therapy as the Maintenance Therapy in Patients with Autoimmune Neuromuscular Disease - A Prospective Study.
Feasibility of Subcutaneous Immunoglobulin therapy as the Maintenance Therapy in Patients with Autoimmune Neuromuscular Disease - A Prospective Study.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: September 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Siddiqi's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile